"Death, Sudden, Cardiac" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Descriptor ID |
D016757
|
| MeSH Number(s) |
C14.280.383.220 C23.550.260.322.250
|
| Concept/Terms |
Death, Sudden, Cardiac- Death, Sudden, Cardiac
- Sudden Cardiac Death
- Cardiac Death, Sudden
- Death, Sudden Cardiac
- Cardiac Sudden Death
- Death, Cardiac Sudden
- Sudden Death, Cardiac
Sudden Cardiac Arrest- Sudden Cardiac Arrest
- Arrest, Sudden Cardiac
- Cardiac Arrests, Sudden
- Cardiac Arrest, Sudden
|
Below are MeSH descriptors whose meaning is more general than "Death, Sudden, Cardiac".
Below are MeSH descriptors whose meaning is more specific than "Death, Sudden, Cardiac".
This graph shows the total number of publications written about "Death, Sudden, Cardiac" by people in this website by year, and whether "Death, Sudden, Cardiac" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 3 | 1 | 4 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Death, Sudden, Cardiac" by people in Profiles.
-
Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States. J Am Heart Assoc. 2023 08; 12(15):e029126.
-
Pharmacotherapy in Ventricular Arrhythmias. Cardiology. 2023; 148(2):119-130.
-
Letter by Madias and Madias Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial". Circulation. 2022 Jul 26; 146(4):e8-e9.
-
Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far). Am J Cardiol. 2022 04 01; 168:163-165.
-
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2022 01; 33(1):20-29.
-
Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients = 60 Years with Implantable Cardioverter Defibrillator. Am J Cardiol. 2021 08 01; 152:94-98.
-
Cardiac ryanodine receptor calcium release deficiency syndrome. Sci Transl Med. 2021 02 03; 13(579).
-
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants. Circ Arrhythm Electrophysiol. 2020 10; 13(10):e008123.
-
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy. JACC Clin Electrophysiol. 2020 08; 6(8):1019-1021.
-
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy. Am J Cardiol. 2020 08 01; 128:75-83.